After decades of rising obesity and chronic disease, advances in science, technology, and public policy are opening an opportunity to change course. Improving metabolic health – defined as the body’s ability to efficiently produce, regulate, and use energy to sustain daily function – carries implications far beyond healthcare. Poor metabolic health has a high cost for the global economy, driven by increased healthcare spending, reduced workforce participation, lower productivity, and premature mortality. 

According to the McKinsey Health Institute (MHI), improving metabolic health could unlock up to $5.65 trillion in annual global GDP uplift by 2050, making it one of the most powerful yet underused levers for long-term economic resilience. 

The logic is straightforward: healthier populations live longer, work more productively, and also place less strain on health systems.

“Metabolic health sits at the intersection of human wellbeing and economic performance,” says Lars Hartenstein, Partner at McKinsey & Company and Director of Healthy Longevity at MHI. “When we improve metabolic health, we are not just reducing body weight – we are lowering the risk of cardiovascular disease, diabetes, some cancers, and mental health challenges. That directly extends health span, the years people live in good health, and delays age-related decline.”

The economic link is just as clear. Poor metabolic health drives absenteeism, lower productivity, as well as higher healthcare spending.

A GLOBAL INFLECTION POINT

For much of the past five decades, obesity has been often treated as an individual responsibility and metabolic disorders primarily as a clinical matter. Yet these are systemic challenges with profound cumulative health and economic consequences. Globally, metabolic conditions contribute to more than 20 diseases and an estimated 6.5 billion years of life lost, increasingly acting as a brake on economic growth.

“For the past 50 years, obesity has been treated as an almost intractable issue,” Hartenstein says. “New weight-management drugs such as GLP-1s have shown meaningful weight loss and improvements in cardiometabolic markers.” He adds that the advances are drawing renewed attention and investment across governments, employers, investors, and food systems, creating an opening to rethink metabolic health more broadly.

GLP-1s represent a catalytic moment, showing that progress is possible at scale. But the larger opportunity lies in what comes next: whether leaders and societies can use this momentum to shift toward prevention, rather than relying solely on treatment.

MHI frames this shift through two alternative paths.

Path 1 — the treatment-led approach — builds on innovations such as weight-management drugs to treat obesity in people already living with metabolic disease. While it delivers measurable progress, it remains largely reactive.

Path 2 — adding a prevention-led approach — shifts the focus upstream, aiming to prevent metabolic disease through healthier food systems, more active environments, supportive workplace policies, and coordinated public health initiatives. This approach delivers stronger long-term returns by fostering healthier populations, boosting labor participation, and strengthening more resilient economies.

TABLE 2: MHI’s research illustrates the scale of difference between Path 1 and Path 2, reinforcing why prevention represents a generational economic opportunity, rather than a narrow health intervention.

In the Middle East, this transformation is no longer theoretical. Abu Dhabi has launched one of the world’s first population-level metabolic health strategies, with MHI as a collaborator, spanning more than 20 interventions across schools, workplaces, food systems, and public spaces, supported by dedicated governance and data infrastructure.

Hartenstein sees this as an early example of Path 2 in action. “If successful,” he says, “the region could establish the world’s first reference case for a whole-society metabolic-health revolution.”

FIVE SHIFTS FOR A HEALTHIER FUTURE

According to MHI, realizing a metabolic-health revolution will depend on progress across five interconnected shifts: science, transparency, technology, economy, and society.

Hartenstein highlights transparency and economic alignment as particularly urgent.  “Without better transparency, we are essentially flying blind,” he says. “Most countries lack robust systems to measure and track metabolic health for individuals and populations. Improved biofeedback and population-level metrics can show people, providers, and policymakers where risks are concentrated and whether interventions are working.”

The economic shift, he adds, is equally critical. Today, many incentives still favor high-calorie, low-nutrient products and sedentary lifestyles. Aligning economic systems so that healthier choices become more affordable, accessible, and desirable is key to sustained change.

Hartenstein notes that when transparency and economic incentives move in the right direction, they create the foundation for the other shifts in science, technology, and society. Together, they form a framework for turning today’s momentum into meaningful, lasting progress.

WHY THE MIDDLE EAST IS POISED TO LEAD

Few regions face as urgent, or as promising, a moment of transformation as the Middle East. The region has some of the highest rates of obesity and diabetes in the world, yet also one of the strongest political mandates and investment appetites for large-scale health transformation.

“Many countries in the Middle East sit at a metabolic-health crossroads,” Hartenstein notes. “Across the region, metabolic risks such as high blood sugar, blood pressure, and lipid disorders contribute to a far greater share of disease burden than high BMI alone — underscoring why focusing only on obesity misses much of the challenge.”

That recognition is translating into action. While Abu Dhabi provides an early reference point, momentum is broadening across the region. Saudi Arabia is advancing workplace wellness and nutrition reforms. The UAE is embedding prevention into urban design and early screening programs. For people across the Gulf, this signals a shift from managing illness reactively to embedding prevention into everyday life, from what children eat at school to how adults engage with work and movement.

“This combination of high need, strong political will, and willingness to innovate uniquely positions Middle Eastern countries to turn Path 2 from concept into practice – showing how cross-sector investment can improve metabolic health and strengthen economic resilience,” says Hartenstein. 

THE NEXT CHAPTER FOR METABOLIC HEALTH

The Middle East’s progress offers a compelling glimpse of what transformation could look like. Through its national health visions, investment appetite, and youthful population, the region is positioned to pioneer a model for prevention-driven prosperity.

The emerging initiatives in Abu Dhabi, supported by cross-sector collaboration and data-driven planning, signal how a Path 2 approach can take shape in practice – one that embeds health outcomes into the fabric of economic development. This multi-sectoral vision mirrors the broader transformation agendas seen across the Gulf, where governments are aligning innovation, health, and human capital as part of long-term growth strategies.

A metabolic-health future is one where prevention is built into daily life – where healthy food environments, active cities, digital tools, and supportive workplaces make the healthy choice the easy choice. It’s a future that extends health span, lifts productivity, and strengthens economic resilience across generations.

For the rest of the world, the Middle East’s experience could become a blueprint for what large-scale, coordinated health transformation looks like in practice, proving that economic diversification and population wellbeing can advance hand in hand.

As Hartenstein emphasizes, realizing that potential will require bold leadership and sustained collaboration. Governments can build transparent, data-driven health systems. Businesses can invest in prevention and wellbeing as a productivity strategy. And innovators can design technologies that make healthier living accessible for all.

The choices made now will determine whether the region, and the world, follow an incremental path or a truly transformational one. With its ambition, resources, and readiness to act, the Middle East has the potential to demonstrate how prevention-driven health systems can serve as a foundation for long-term economic growth, at home and globally.